Free Trial
OTCMKTS:BIOVF

Swedish Orphan Biovitrum (BIOVF) Stock Price, News & Analysis

Swedish Orphan Biovitrum logo
$28.97 -0.82 (-2.75%)
As of 08/12/2025 03:29 PM Eastern

About Swedish Orphan Biovitrum Stock (OTCMKTS:BIOVF)

Key Stats

Today's Range
$28.94
$28.97
50-Day Range
$27.06
$31.99
52-Week Range
$25.80
$32.25
Volume
500 shs
Average Volume
54 shs
Market Capitalization
$10.31 billion
P/E Ratio
24.34
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive BIOVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Swedish Orphan Biovitrum and its competitors with MarketBeat's FREE daily newsletter.

BIOVF Stock News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
See More Headlines

BIOVF Stock Analysis - Frequently Asked Questions

Swedish Orphan Biovitrum's stock was trading at $27.66 at the beginning of the year. Since then, BIOVF stock has increased by 4.7% and is now trading at $28.97.

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) posted its earnings results on Wednesday, July, 16th. The company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.18 by $0.06. The company earned $649.61 million during the quarter, compared to analyst estimates of $644.68 million. Swedish Orphan Biovitrum had a net margin of 16.05% and a trailing twelve-month return on equity of 11.67%.

Shares of BIOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/16/2025
Today
8/14/2025
Next Earnings (Estimated)
10/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
OTCMKTS:BIOVF
CIK
N/A
Fax
N/A
Employees
1,937
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
$1.19
Trailing P/E Ratio
24.34
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$367.52 million
Net Margins
16.05%
Pretax Margin
18.72%
Return on Equity
11.67%
Return on Assets
6.34%

Debt

Debt-to-Equity Ratio
0.22
Current Ratio
1.00
Quick Ratio
0.66

Sales & Book Value

Annual Sales
$2.46 billion
Price / Sales
4.19
Cash Flow
$2.05 per share
Price / Cash Flow
14.12
Book Value
$11.36 per share
Price / Book
2.55

Miscellaneous

Outstanding Shares
356,000,000
Free Float
N/A
Market Cap
$10.31 billion
Optionable
Not Optionable
Beta
0.46

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:BIOVF) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners